Related Experiment Video
Updated: Jul 17, 2025

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Clostridioides difficile Infection in Pediatric Inflammatory Bowel Disease
Seth A Reasoner1, Maribeth R Nicholson2,3
1Division of Molecular Pathogenesis, Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Children with inflammatory bowel disease (IBD) face higher rates of Clostridioides difficile infection (CDI). Current diagnostic tests are insufficient, and specialized care is crucial for managing this vulnerable population.
Area of Science:
- Pediatric Gastroenterology
- Infectious Diseases
- Microbiome Research
Background:
- Children with inflammatory bowel disease (IBD) exhibit an increased susceptibility to Clostridioides difficile infection (CDI).
- Outcomes for pediatric IBD patients with CDI are often more severe compared to the general pediatric population.
Purpose of the Study:
- To review current research on the incidence, diagnosis, complications, and treatment of CDI in pediatric IBD patients.
- To highlight the unique challenges and considerations for managing CDI in this specific demographic.
Main Methods:
- Literature review of recent studies on CDI in pediatric IBD.
- Analysis of diagnostic accuracy and treatment efficacy for CDI in children with IBD.
Main Results:
- Pediatric IBD patients show a higher incidence of CDI, independent of typical adult risk factors.
- Current diagnostic methods struggle to distinguish CDI from colonization in this group.
- Fecal microbiota transplantation demonstrates effectiveness for recurrent CDI.
Conclusions:
- CDI is a significant concern in children with IBD, necessitating vigilant clinical monitoring.
- Patients with co-occurring IBD and CDI require close surveillance for adverse outcomes.
- Further research is essential to optimize diagnostic and therapeutic strategies for CDI in pediatric IBD.
More Related Videos
06:51Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
09:12A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...